Article
Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies.
Blood - 15 Nov 1999
Cardoso A A, Veiga J P, Ghia P, Afonso H M, Haining W N, Sallan S E, Nadler L M
Abstract excerpt
We have previously shown that leukemia-specific cytotoxic T cells (CTL) can be generated from the bone marrow of most patients with B-cell precursor acute leukemias. If these antileukemia CTL are to be used for adoptive immunotherapy, they must have the capability to circulate, migrate through endothelium, home to the bone marrow, and, most importantly, lyse the leukemic cells in a leukemia-permissive bone marrow...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
